Replies to post #798219 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Nope. The B rooms are producing L. The two non-adjacent C grade clean rooms are not built. If you are saying there are another 2 C built grade clean rooms producing DCVax tech (beyond the non-built ones), NWBO would have mentioned them. They have not. In fact they’ve gone out of their way to say in the 10k that they would build the simplified C room first in lieu of any other C room for production of DCVax.

[FeMike]

The Sawston facility already has licensed, operational Grade B, Grade C and Grade D cleanrooms. That is not conjecture. It is documented in Advent’s MHRA Manufacturing and Import Authorisations and in the UK Cell and Gene Therapy Catapult report, which lists Advent with two Grade B suites, three Grade C rooms and two Grade D rooms. MHRA only licenses rooms that already exist, have been inspected and have passed environmental and process validation. Those rooms have been in active use for years for ATMP manufacturing, including DCVax production during the Phase 3 extension period, Specials supply and validation runs…the existing Grade C cleanrooms are part of the current DCVax manufacturing layout. They serve different purposes, appear in different sections of the filings and exist on different timelines

Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility

Welll this is awkward. Dr AI was wrong again? Man I feel shocked.